Mohammad Rabiei

Dr. Mohammad Rabiei is an accomplished virologist affiliated with the Gastrointestinal Viral Oncology group at the Ingham Institute for Applied Medical Research and UNSW Medicine & Health. With over 16 years of academic expertise in Australia and Iran, he holds a PhD in Virology (2021) from the University of Adelaide and has received prestigious awards like the

• Adelaide Graduate Award
• UNSW Faculty of Medicine Research Engagement Award

. His research focuses on oncogenic viruses, particularly HPV's role in oesophageal and gastric cancers, while leading collaborative projects across institutions like UNSW, University of Sydney, and Murdoch Children's Research Institute.

Dr. Rabiei's academic journey includes a

• PhD in Virology, University of Adelaide (2021)
• MSc in Medical Microbiology, Shahrekord University of Medical Sciences (2013)
• BSc in Medical Laboratory Sciences, Semnan University (2002)
• Associate Degree in Veterinary Medicine, Shahrekord University (1999)

.

His research spans molecular pathogenesis of Newcastle disease virus, virus-host interactions (including the RADD patent), and antimicrobial resistance in pathogens like

• Staphylococcus aureus
• Escherichia coli
• Lactococcus garvieae

. He supervises two PhD students and one Honours student, with publications on viral oncology, influenza inhibition by pomegranate extract, and RAPD-PCR for pathogen characterization.

Scientific awards include

• Adelaide Graduate Award (2020)
• Research Incentive Publication Award (2019, 2021)
• Scholarships from University of Adelaide (2017-2021)

, alongside leadership roles in academic networks like the Ingham Institute Postdoc Association and UNSW's Early Career Academic Network.